|
[1]
|
Cushing, H. (1930) Experiences with the Cerebellar Medulloblastomas: A Critical Review. Acta Pathologica Microbiologica Scandinavica, 1, 1-86. [Google Scholar] [CrossRef]
|
|
[2]
|
Kool, M., Korshunov, A., Remke, M., Jones, D.T., Schlanstein, M., Northcott, P.A., et al. (2012) Molecular Subgroups of Medulloblastoma: An International Meta-Analysis of Transcriptome, Genetic Aberrations, and Clinical Data of WNT, SHH, Group 3, and Group 4 Medulloblastoma. Acta Neuropathologica, 123, 473-484. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Taylor, M.D., Northcott, P.A., Korshunov, A., Remke, M., Cho, Y.J., Clifford, S.C., et al. (2012) Molecular Subgroups of Medulloblastoma: The Current Consensus. Acta Neuropathologica, 123, 465-472. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Thompson, M.C., Fuller, C., Hogg, T.L., Dalton, J., Finkelstein, D., Lau, C.C., et al. (2006) Genomics Identifies Medulloblastoma Subgroups That Are Enriched for Specific Genetic Alterations. Journal of Clinical Oncology, 24, 1924-1931. [Google Scholar] [CrossRef]
|
|
[5]
|
Northcott, P.A., Korshunov, A., Witt, H., Hielscher, T., Eberhart, C.G., Mack, S., et al. (2011) Medulloblastoma Comprises Four Distinct Molecular Variants. Journal of Clinical Oncology, 29, 1408-1414. [Google Scholar] [CrossRef]
|
|
[6]
|
Shih, D.J., Northcott, P.A., Remke, M., Korshunov, A., Ramaswamy, V., Kool, M., Luu, B., et al. (2014) Cytogenetic Prognostication within Medulloblastoma Subgroups. Journal of Clinical Oncology, 32, 886-896. [Google Scholar] [CrossRef]
|
|
[7]
|
Northcott, P.A., Shih, D.J., Remke, M., Cho, Y.J., Kool, M., Hawkins, C., et al. (2012) Rapid, Reliable, and Reproducible Molecular Sub-Grouping of Clinical Medulloblastoma Samples. Acta Neuropathologica, 123, 615-626. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Northcott, P.A., Shih, D.J., Peacock, J., Garzia, L., Morrissy, A.S., Zichner, T., et al. (2012) Subgroup-Specific Structural Variation across 1,000 Medulloblastoma Genomes. Nature, 488, 49-56. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Pai Panandiker, A., Ning, H., Likhacheva, A., Ullman, K., Arora, B., Ondos, J., et al. (2007) Craniospinal Irradiation with Spinal IMRT to Improve Target Homogeneity. International Journal of Radiation Oncology, Biology, Physics, 68, 1402-1409. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Parker, W., Filion, E., Roberge, D. and Freeman, C.R. (2007) Intensity-Modulated Radiotherapy for Craniospinal Irradiation: Target Volume Considerations, Dose Constraints, and Competing Risks. International Journal of Radiation Oncology, Biology, Physics, 69, 251-257. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Millard, N.E. and De Braganca, K.C. (2016) Medulloblastoma. Journal of Child Neurology, 31, 1341-1353. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Hughes, E.N., Shillito, J., Sallan, S.E., Loeffler, J.S., Cassady, J.R. and Tarbell, N.J. (1988) Medulloblastoma at the Joint Center for Radiation Therapy between 1968 and 1984. The Influence of Radiation Dose on the Patterns of Failure and Survival. Cancer, 61, 1992-1998. [Google Scholar] [CrossRef]
|
|
[13]
|
del Charco, J.O., Bolek, T.W., McCollough, W.M., Maria, B.L., Kedar, A., Braylan, R.C., et al. (1998) Medulloblastoma: Time-Dose Relationship Based on a 30-Year Review. International Journal of Radiation Oncology, Biology, Physics, 42, 147-154. [Google Scholar] [CrossRef]
|
|
[14]
|
Merchant, T.E., Kun, L.E., Krasin, M.J., Wallace, D., Chintagumpala, M.M., Woo, S.Y., et al. (2008) Multi-Institution Prospective Trial of Reduced-Dose Craniospinal Irradiation (23.4 Gy) Followed by Conformal Posterior Fossa (36 Gy) and Primary Site Irradiation (55.8 Gy) and Dose-Intensive Chemotherapy for Average-Risk Medulloblastoma. International Journal of Radiation Oncology, Biology, Physics, 70, 782-787. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Lannering, B., Rutkowski, S., Doz, F., Pizer, B., Gustafsson, G., Navajas, A., et al. (2012) Hyperfractionated versus Conventional Radiotherapy Followed by Chemotherapy in Standard-Risk Medulloblastoma: Results from the Randomized Multicenter HIT-SIOP PNET 4 Trial. Journal of Clinical Oncology, 30, 3187-3193. [Google Scholar] [CrossRef]
|
|
[16]
|
Packer, R.J., Goldwein, J., Nicholson, H.S., Vezina, L.G., Allen, J.C., Ris, M.D., et al. (1999) Treatment of Children with Medulloblastomas with Reduced-Dose Craniospinal Radiation Therapy and Adjuvant Chemotherapy: A Children's Cancer Group Study. Journal of Clinical Oncology, 17, 2127. [Google Scholar] [CrossRef]
|
|
[17]
|
Gajjar, A., Chintagumpala, M., Ashley, D., Kellie, S., Kun, L.E., Merchant, T.E., et al. (2006) Risk-Adapted Craniospinal Radiotherapy Followed by High-Dose Chemotherapy and Stem-Cell Rescue in Children with Newly Diagnosed Medulloblastoma (St Jude Medulloblastoma-96): Long-Term Results from a Prospective, Multicentre Trial. Lancet Oncology, 7, 813-820. Erratum in: Lancet Oncology, 7, 797. [Google Scholar] [CrossRef]
|
|
[18]
|
Packer, R.J., Siegel, K.R., Sutton, L.N., Evans, A.E., D’Angio, G., Rorke, L.B., Bunin, G.R. and Schut, L. (1988) Efficacy of Adjuvant Chemotherapy for Patients with Poor-Risk Medulloblastoma: A Preliminary Report. Annals of Neurology, 24, 503-508. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Packer, R.J., Sutton, L.N., Elterman, R., Lange, B., Goldwein, J., Nicholson, H.S., Mulne, L., Boyett, J., D’Angio, G., Wechsler-Jentzsch, K., et al. (1994) Outcome for Children with Medulloblastoma Treated with Radiation and Cisplatin, CCNU, and Vincristine Chemotherapy. Journal of Neurosurgery, 81, 690-698. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Gandola, L., Massimino, M., Cefalo, G., Solero, C., Spreafico, F., Pecori, E., Riva, D., et al. (2008) Hyperfractionated Accelerated Radiotherapy in the Milan Strategy for Metastatic Medulloblastoma. Journal of Clinical Oncology, 27, 566-571. [Google Scholar] [CrossRef]
|
|
[21]
|
Padovani, L., Horan, G. and Ajithkumar, T. (2019) Radiotherapy Advances in Paediatric Medulloblastoma Treatment. Clinical Oncology, 31, 171-181. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Rutkowski, S., Gerber, N.U., von Hoff, K., Gnekow, A., Bode, U., Graf, N., et al. (2009) Treatment of Early Childhood Medulloblastoma by Postoperative Chemotherapy and Deferred Radiotherapy. Neuro-Oncology, 11, 201-210. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Ashley, D.M., Merchant, T.E., Strother, D., Zhou, T., Duffner, P., Burger, P.C., Miller, D.C., et al. (2012) Induction chemotherapy and Conformal Radiation Therapy for Very Young Children with Nonmetastatic Medulloblastoma: Children’s Oncology Group Study P9934. Journal of Clinical Oncology, 30, 3181-3186. [Google Scholar] [CrossRef]
|
|
[24]
|
Bowers, D.C., Gargan, L., Weprin, B.E., Mulne, A.F., Elterman, R.D., Munoz, L., Giller, C.A. and Winick, N.J. (2007) Impact of Site of Tumor Recurrence Upon Survival for Children with Recurrent or Progressive Medulloblastoma. Journal of Neurosurgery, 107, 5-10. [Google Scholar] [CrossRef]
|
|
[25]
|
Dunkel, I.J., Gardner, S.L., Garvin Jr., J.H., Goldman, S., Shi, W. and Finlay, J.L. (2010) High-Dose Carboplatin, Thiotepa, and Etoposide with Autologous Stem Cell Rescue for Patients with Previously Irradiated Recurrent Medulloblastoma. Neuro-Oncology, 12, 297-303. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Kadota, R.P., Mahoney, D.H., Doyle, J., Duerst, R., Friedman, H., Holmes, E., Kun, L., Zhou, T. and Pollack, I.F. (2008) Dose Intensive Melphalan and Cyclophosphamide with Autologous Hematopoietic Stem Cells for Recurrent Medulloblastoma or Germinoma. Pediatric Blood & Cancer, 51, 675-678. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Milker-Zabel, S., Zabel, A., Thilmann, C., Zuna, I., Hoess, A., Wannenmacher, M. and Debus, J. (2002) Results of Three-Dimensional Stereotactically-Guided Radiotherapy in Recurrent Medulloblastoma. Journal of Neuro-Oncology, 60, 227-233. [Google Scholar] [CrossRef]
|
|
[28]
|
Wetmore, C., Herington, D., Lin, T., Onar-Thomas, A., Gajjar, A. and Merchant, T.E. (2014) Reirradiation of Recurrent Medulloblastoma: Does Clinical Benefit Outweigh Risk for Toxicity? Cancer, 120, 3731-3737. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Bakst, R.L., Dunkel, I.J., Gilheeney, S., Khakoo, Y., Becher, O., Souweidane, M.M. and Wolden, S.L. (2011) Reirradiation for Recurrent Medulloblastoma. Cancer, 117, 4977-4982. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Yamada, A., Moritake, H., Kamimura, S., Yamashita, S., Takeshima, H. and Nunoi, H. (2014) Proposed Strategy for the Use of High-Dose Chemotherapy with Stem Cell Rescue and Intrathecal Topotecan without Whole-Brain Irradiation for Infantile Classic Medulloblastoma. Pediatric Blood & Cancer, 61, 2316-2318. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Aguilera, D., Mazewski, C., Fangusaro, J., MacDonald, T.J., McNall-Knapp, R.Y., Hayes, L.L., Kim, S. and Castellino, R.C. (2013) Response to Bevacizumab, Irinotecan, and Temozolomide in Children with Relapsed Medulloblastoma: A Multi-Institutional Experience. Child’s Nervous System, 29, 589-596. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Ashley, D.M., Meier, L., Kerby, T., Zalduondo, F.M., Friedman, H.S., Gajjar, A., et al. (1996) Response of Recurrent Medulloblastoma to Low-Dose Oral Etoposide. Journal of Clinical Oncology, 14, 1922-1927. [Google Scholar] [CrossRef]
|
|
[33]
|
Gururangan, S., Krauser, J., Watral, M.A., Driscoll, T., Larrier, N., Reardon, D.A., et al. (2008) Efficacy of High-Dose Chemotherapy or Standard Salvage Therapy in Patients with Recurrent Medulloblastoma. Neuro-Oncology, 10, 745-751. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Dunkel, I.J., Boyett, J.M., Yates, A., Rosenblum, M., Garvin Jr., J.H., Bostrom, B.C., et al. (1998) High-Dose Carboplatin, Thiotepa, and Etoposide with Autologous Stem-Cell Rescue for Patients with Recurrent Medulloblastoma. Children’s Cancer Group. Journal of Clinical Oncology, 16, 222-228. [Google Scholar] [CrossRef]
|
|
[35]
|
Packer, R.J., Gajjar, A., Vezina, G., Rorke-Adams, L., Burger, P.C., Robertson, P.L., et al. (2006) Phase III Study of Craniospinal Radiation Therapy Followed by Adjuvant Chemotherapy for Newly Diagnosed Average-Risk Medulloblastoma. Journal of Clinical Oncology, 24, 4202-4208. [Google Scholar] [CrossRef]
|
|
[36]
|
Mizumoto, M., Murayama, S., Akimoto, T., Demizu, Y., Fukushima, T., Ishida, Y., et al. (2016) Proton Beam Therapy for Pediatric Malignancies: A Retrospective Observational Multicenter Study in Japan. Cancer Medicine, 5, 1519-1525. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Mizumoto, M., Murayama, S., Akimoto, T., Demizu, Y., Fukushima, T., Ishida, Y., et al. (2017) Long-Term Follow-up after Proton Beam Therapy for Pediatric Tumors: A Japanese National Survey. Cancer Science, 108, 444-447. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Gordon, J. and Siebers, J. (2013) Addressing a Gap in Current IMRT Quality Assurance. International Journal of Radiation Oncology, Biology, Physics, 87, 20-21. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Eaton, B.R., Esiashvili, N., Kim, S., Patterson, B., Weyman, E.A., Thornton, L.T., et al. (2016) Endocrine Outcomes with Proton and Photon Radiotherapy for Standard Risk Medulloblastoma. Neuro-Oncology, 18, 881-887. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Yock, T.I., Yeap, B.Y., Ebb, D.H., Weyman, E., Eaton, B.R., Sherry, N.A., et al. (2016) Long-Term Toxic Effects of Proton Radiotherapy for Paediatric Medulloblastoma: A Phase 2 Single-Arm Study. Lancet Oncology, 17, 287-298. Erratum in: Lancet Oncology, 21, e132. [Google Scholar] [CrossRef]
|
|
[41]
|
Kahalley, L.S., Peterson, R., Ris, M.D., Janzen, L., Okcu, M.F., Grosshans, D.R., et al. (2020) Superior Intellectual Outcomes after Proton Radiotherapy Compared With Photon Radiotherapy for Pediatric Medulloblastoma. Journal of Clinical Oncology, 38, 454-461. [Google Scholar] [CrossRef]
|
|
[42]
|
Brodin, N.P., Munck af Rosenschöld, P., Blomstrand, M., Kiil-Berthlesen, A., Hollensen, C., Vogelius, I.R., et al. (2014) Hippocampal Sparing Radiotherapy for Pediatric Medulloblastoma: Impact of Treatment Margins and Treatment Technique. Neuro-Oncology, 16, 594-602. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Pulsifer, M.B., Sethi, R.V., Kuhlthau, K.A., MacDonald, S.M., Tarbell, N.J. and Yock, T.I. (2015) Early Cognitive Outcomes Following Proton Radiation in Pediatric Patients with Brain and Central Nervous System Tumors. International Journal of Radiation Oncology, Biology, Physics, 93, 400-407. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
St Clair, W.H., Adams, J.A., Bues, M., Fullerton, B.C., La Shell, S., Kooy, H.M., et al. (2004) Advantage of Protons Compared to Conventional X-Ray or IMRT in the Treatment of a Pediatric Patient with Medulloblastoma. International Journal of Radiation Oncology, Biology, Physics, 58, 727-734. [Google Scholar] [CrossRef]
|
|
[45]
|
Yuh, G.E., Loredo, L.N., Yonemoto, L.T., Bush, D.A., Shahnazi, K., Preston, W., et al. (2004) Reducing Toxicity from Craniospinal Irradiation: Using Proton Beams to Treat Medulloblastoma in Young Children. Cancer Journal, 10, 386-390. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Guruangan, S., Dunkel, I.J., Goldman, S., Garvin, J.H., Rosenblum, M., Boyett, J.M., et al. (1998) Myeloablative Chemotherapy with Autologous Bone Marrow Rescue in Young Children with Recurrent Malignant Brain Tumors. Journal of Clinical Oncology, 16, 2486-2493. [Google Scholar] [CrossRef]
|
|
[47]
|
Eaton, B.R., Esiashvili, N., Kim, S., Weyman, E.A., Thornton, L.T., Mazewski, C., et al. (2016) Clinical Outcomes among Children with Standard-Risk Medulloblastoma Treated with Proton and Photon Radiation Therapy: A Comparison of Disease Control and Overall Survival. International Journal of Radiation Oncology, Biology, Physics, 94, 133-138. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
Zhang, R., Howell, R.M., Giebeler, A., Taddei, P.J., Mahajan, A. and Newhauser, W.D. (2013) Comparison of Risk of Radiogenic Second Cancer Following Photon and Proton Craniospinal Irradiation for a Pediatric Medulloblastoma Patient. Physics in Medicine & Biology, 58, 807-823. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
Fernandes, R.R.A., Vianna, C.M.M., Guerra, R.L., Cancela, M.C., Almeida, L.M., Pereira, A.J.D.C., et al. (2019) Cost-Effectiveness of Proton versus Photon Therapy in Pediatric Medulloblastoma Treatment: A Patient Volume-Based Analysis. Value in Health Regional Issues, 20, 122-128. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Packer, R.J., Zhou, T., Holmes, E., Vezina, G. and Gajjar, A. (2013) Survival and Secondary Tumors in Children with Medulloblastoma Receiving Radiotherapy and Adjuvant Chemotherapy: Results of Children’s Oncology Group Trial A9961. Neuro-Oncology, 15, 97-103. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Khatua, S., Song, A., Citla Sridhar, D. and Mack, S.C. (2018) Childhood Medulloblastoma: Current Therapies, Emerging Molecular Landscape and Newer Therapeutic Insights. Current Neuropharmacology, 16, 1045-1058. [Google Scholar] [CrossRef]
|
|
[52]
|
von Bueren, A.O., von Hoff, K., Pietsch, T., Gerber, N.U., Warmuth-Metz, M., Deinlein, F., et al. (2011) Treatment of Young Children with Localized Medulloblastoma by Chemotherapy Alone: Results of the Prospective, Multicenter Trial HIT 2000 Confirming the Prognostic Impact of Histology. Neuro-Oncology, 13, 669-679. [Google Scholar] [CrossRef] [PubMed]
|